chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Nausea, Pain
Clinical narrative: Strong pain; Itchy throat; Cough; Fever; Nausea; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever) and NAUSEA (Nausea) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants or treatment medications were reported.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Throat irritation
Clinical narrative: Strong pain; Itchy throat; Cough; Fever; Nausea; Headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever) and NAUSEA (Nausea) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, PAIN (Strong pain), THROAT IRRITATION (Itchy throat), COUGH (Cough), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants or treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Little redness but went away; Redness at the vaccination site; Size of half a dollar; Warm; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Size of half a dollar), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (Little redness but went away) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE MASS (Size of half a dollar), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Little redness but went away). At the time of the report, VACCINATION SITE MASS (Size of half a dollar), VACCINATION SITE WARMTH (Warm), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site) outcome was unknown and VACCINATION SITE ERYTHEMA (Little redness but went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itches; A rash 1.5-inch in diameter at inject site; bumps; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itches), VACCINATION SITE RASH (A rash 1.5-inch in diameter at inject site) and VACCINATION SITE SWELLING (bumps) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa allergy) and Food allergy.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itches), VACCINATION SITE RASH (A rash 1.5-inch in diameter at inject site) and VACCINATION SITE SWELLING (bumps). At the time of the report, VACCINATION SITE PRURITUS (Itches), VACCINATION SITE RASH (A rash 1.5-inch in diameter at inject site) and VACCINATION SITE SWELLING (bumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site reaction, Vaccination site warmth
Clinical narrative: COVID arm; Area below the injection site hard; Area below the injection site raspberry red; Area below the injection site hot; Left arm itching, area below the injection site itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Area below the injection site hot), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (Left arm itching, area below the injection site itchy), VACCINATION SITE INDURATION (Area below the injection site hard) and VACCINATION SITE ERYTHEMA (Area below the injection site raspberry red) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included GERD. Concomitant products included PANTOPRAZOLE for GERD, VITAMIN D2, ESCITALOPRAM and SIMVASTATIN (STATIN [SIMVASTATIN]) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Left arm itching, area below the injection site itchy). On 10-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Area below the injection site hot), VACCINATION SITE INDURATION (Area below the injection site hard) and VACCINATION SITE ERYTHEMA (Area below the injection site raspberry red). On 11-Feb-2021, the patient experienced VACCINATION SITE REACTION (COVID arm). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pruritus, Vaccination site induration, Vaccination site erythema, Vaccination site warmth and Vaccination site reaction, at an unspecified dose and frequency and NONOXINOL, SODIUM LAURYL SULFATE (POISON IVY [NONOXINOL;SODIUM LAURYL SULFATE]) for Vaccination site pruritus, Vaccination site induration, Vaccination site erythema, Vaccination site reaction and Vaccination site warmth, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Area below the injection site hot), VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (Left arm itching, area below the injection site itchy), VACCINATION SITE INDURATION (Area below the injection site hard) and VACCINATION SITE ERYTHEMA (Area below the injection site raspberry red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: hardening of the area; pain and soreness in left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029k20) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm). At the time of the report, VACCINATION SITE INDURATION (hardening of the area) and VACCINATION SITE PAIN (pain and soreness in left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Cold sweat, Dyspnoea, Electrocardiogram
Clinical narrative: elevated heartrate; clammy in her feet; anxious; wheezing; allergic reaction; rash on chest/rash on cheeks; extremely hot and sweaty; face was completely numb; hard time breathing; increased heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty) and HYPOAESTHESIA (face was completely numb) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIPOTRIOL (CALCITRENE), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ALPRAZOLAM (XANAX) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate) and RASH (rash on chest/rash on cheeks). On 15-Feb-2021, the patient experienced WHEEZING (wheezing) and HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet) and ANXIETY (anxious). The patient was treated with LORAZEPAM at an unspecified dose and frequency and DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate), WHEEZING (wheezing), HYPERSENSITIVITY (allergic reaction) and RASH (rash on chest/rash on cheeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal. On an unknown date, Electrocardiogram: normal. On an unknown date, X-ray: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included steroids.   This case was linked to MOD-2021-012336 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: No specific follow-up information recorded.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hyperhidrosis, Hypersensitivity, Hypoaesthesia, Rash
Clinical narrative: elevated heartrate; clammy in her feet; anxious; wheezing; allergic reaction; rash on chest/rash on cheeks; extremely hot and sweaty; face was completely numb; hard time breathing; increased heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty) and HYPOAESTHESIA (face was completely numb) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIPOTRIOL (CALCITRENE), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ALPRAZOLAM (XANAX) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate) and RASH (rash on chest/rash on cheeks). On 15-Feb-2021, the patient experienced WHEEZING (wheezing) and HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet) and ANXIETY (anxious). The patient was treated with LORAZEPAM at an unspecified dose and frequency and DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate), WHEEZING (wheezing), HYPERSENSITIVITY (allergic reaction) and RASH (rash on chest/rash on cheeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal. On an unknown date, Electrocardiogram: normal. On an unknown date, X-ray: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included steroids.   This case was linked to MOD-2021-012336 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: No specific follow-up information recorded.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing, X-ray
Clinical narrative: elevated heartrate; clammy in her feet; anxious; wheezing; allergic reaction; rash on chest/rash on cheeks; extremely hot and sweaty; face was completely numb; hard time breathing; increased heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty) and HYPOAESTHESIA (face was completely numb) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIPOTRIOL (CALCITRENE), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and ALPRAZOLAM (XANAX) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate) and RASH (rash on chest/rash on cheeks). On 15-Feb-2021, the patient experienced WHEEZING (wheezing) and HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet) and ANXIETY (anxious). The patient was treated with LORAZEPAM at an unspecified dose and frequency and DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, HEART RATE INCREASED (elevated heartrate), COLD SWEAT (clammy in her feet), ANXIETY (anxious), HYPERHIDROSIS (extremely hot and sweaty), HYPOAESTHESIA (face was completely numb), DYSPNOEA (hard time breathing), HEART RATE INCREASED (increased heart rate), WHEEZING (wheezing), HYPERSENSITIVITY (allergic reaction) and RASH (rash on chest/rash on cheeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal. On an unknown date, Electrocardiogram: normal. On an unknown date, X-ray: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included steroids.   This case was linked to MOD-2021-012336 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Feb-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: hot to the touch; red; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031120A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Diabetes.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 11-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (hot to the touch) had not resolved and VACCINATION SITE PAIN (sore arm) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants or treatment medications were reported.   Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Vaccination complication, Vaccination site erythema, Vaccination site mass
Clinical narrative: She has itchiness; Warm around the injection site area; Felt like she was vaccinated again; Red around the injection site area; A bump on the injection site; Initially she had arm pain; Initially swelling on injection site, a bump on the injection site, she woke up with swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like she was vaccinated again), VACCINATION SITE MASS (A bump on the injection site), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and MYALGIA (Initially she had arm pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Diabetes.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE MASS (A bump on the injection site), MYALGIA (Initially she had arm pain) and VACCINATION SITE SWELLING (Initially swelling on injection site, a bump on the injection site, she woke up with swelling). On 08-Feb-2021, the patient experienced VACCINATION COMPLICATION (Felt like she was vaccinated again), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and VACCINATION SITE ERYTHEMA (Red around the injection site area). At the time of the report, VACCINATION COMPLICATION (Felt like she was vaccinated again), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and VACCINATION SITE ERYTHEMA (Red around the injection site area) outcome was unknown and VACCINATION SITE MASS (A bump on the injection site), MYALGIA (Initially she had arm pain) and VACCINATION SITE SWELLING (Initially swelling on injection site, a bump on the injection site, she woke up with swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: She has itchiness; Warm around the injection site area; Felt like she was vaccinated again; Red around the injection site area; A bump on the injection site; Initially she had arm pain; Initially swelling on injection site, a bump on the injection site, she woke up with swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like she was vaccinated again), VACCINATION SITE MASS (A bump on the injection site), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and MYALGIA (Initially she had arm pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Diabetes.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE MASS (A bump on the injection site), MYALGIA (Initially she had arm pain) and VACCINATION SITE SWELLING (Initially swelling on injection site, a bump on the injection site, she woke up with swelling). On 08-Feb-2021, the patient experienced VACCINATION COMPLICATION (Felt like she was vaccinated again), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and VACCINATION SITE ERYTHEMA (Red around the injection site area). At the time of the report, VACCINATION COMPLICATION (Felt like she was vaccinated again), PRURITUS (She has itchiness), VACCINATION SITE WARMTH (Warm around the injection site area) and VACCINATION SITE ERYTHEMA (Red around the injection site area) outcome was unknown and VACCINATION SITE MASS (A bump on the injection site), MYALGIA (Initially she had arm pain) and VACCINATION SITE SWELLING (Initially swelling on injection site, a bump on the injection site, she woke up with swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Insomnia, Vaccination site pain, Vaccination site swelling
Clinical narrative: did not sleep all night; lot of chills; Pain in arm; swollen; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (lot of chills), VACCINATION SITE PAIN (Pain in arm), VACCINATION SITE SWELLING (swollen) and INSOMNIA (did not sleep all night) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced CHILLS (lot of chills), VACCINATION SITE PAIN (Pain in arm) and VACCINATION SITE SWELLING (swollen). On an unknown date, the patient experienced INSOMNIA (did not sleep all night). At the time of the report, CHILLS (lot of chills), VACCINATION SITE PAIN (Pain in arm), VACCINATION SITE SWELLING (swollen) and INSOMNIA (did not sleep all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Heart rate increased, Hypoacusis
Clinical narrative: Rapid heartbeat; had hearing problem; Very fatigued and weak; Very fatigued and weak; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), HEART RATE INCREASED (Rapid heartbeat), ASTHENIA (Very fatigued and weak), HYPOACUSIS (had hearing problem) and FATIGUE (Very fatigued and weak) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included AFib (She also has a history AFIB).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DIZZINESS (Dizziness) and ASTHENIA (Very fatigued and weak). On an unknown date, the patient experienced HEART RATE INCREASED (Rapid heartbeat), HYPOACUSIS (had hearing problem) and FATIGUE (Very fatigued and weak). At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Very fatigued and weak), HYPOACUSIS (had hearing problem) and FATIGUE (Very fatigued and weak) outcome was unknown and HEART RATE INCREASED (Rapid heartbeat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up was received on 23-APR-2021. Additional event- hypoacusis added.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Pain in extremity, Pyrexia, Vaccination site reaction
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts, soreness in arm), ERYTHEMA (Redness size of two quarters), PYREXIA (A little fever) and VACCINATION SITE REACTION (Arm is leathered and sticky around the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts, soreness in arm), ERYTHEMA (Redness size of two quarters), PYREXIA (A little fever) and VACCINATION SITE REACTION (Arm is leathered and sticky around the injection site). At the time of the report, PAIN IN EXTREMITY (Arm hurts, soreness in arm), ERYTHEMA (Redness size of two quarters), PYREXIA (A little fever) and VACCINATION SITE REACTION (Arm is leathered and sticky around the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: inconclusive (Inconclusive) a little fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Myalgia, Nausea, Pyrexia
Clinical narrative: Feels like she has the flu; Aches all over; Arm hurt very bad; Nauseas; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas) and CHILLS (Chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 11-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided    This case was linked to US-MODERNATX, INC.-MOD-2021-049527 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049527:Patient case for first dose
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Feels like she has the flu; Aches all over; Arm hurt very bad; Nauseas; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas) and CHILLS (Chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 11-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (Feels like she has the flu), MYALGIA (Aches all over), VACCINATION SITE PAIN (Arm hurt very bad), NAUSEA (Nauseas), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication reported  No treatment information was provided    This case was linked to US-MODERNATX, INC.-MOD-2021-049527 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049527:Patient case for first dose
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Myalgia
Clinical narrative: Flu like symptoms; Extreme headache; Tired; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Extreme headache), FATIGUE (Tired) and MYALGIA (Body ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K2019) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Extreme headache), FATIGUE (Tired) and MYALGIA (Body ache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Extreme headache), FATIGUE (Tired) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product use was reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: No New information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. No further information is expected at this time.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with NAPROXEN SODIUM (ALEVE) for Headache, at a dose of Took two Aleve. At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue
Clinical narrative: cough; tired; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and FATIGUE (tired) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, AMLODIPINE and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced COUGH (cough) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (cough) and FATIGUE (tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant and treatment medication include rubinstein calcium.   This case was linked to MOD21-028690 (E2B Linked Report).; Sender's Comments:  MOD21-028690:
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: arm  swelled up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm  swelled up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Urinary tract infection. Concomitant products included CEFDINIR for Urinary tract infection.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PERIPHERAL SWELLING (arm  swelled up). At the time of the report, PERIPHERAL SWELLING (arm  swelled up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Telephone contact report received
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pyrexia
Clinical narrative: Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMOXICILLIN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Consumer received the first dose of the Moderna vaccine on last Thursday and developed fever and headache.  Treatment information was not provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Headache, Pyrexia
Clinical narrative: losing hair; headache; High Fever; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (losing hair), HEADACHE (headache) and PYREXIA (High Fever) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced ALOPECIA (losing hair), HEADACHE (headache) and PYREXIA (High Fever). At the time of the report, ALOPECIA (losing hair), HEADACHE (headache) and PYREXIA (High Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events, a causal relationship cannot be excluded.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Myalgia, Nausea, Vaccination site pain
Clinical narrative: swelling of the lymph node and under the armpit; pain at the injection site, tenderness at the injection site; body ache; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of the lymph node and under the armpit), VACCINATION SITE PAIN (pain at the injection site, tenderness at the injection site), MYALGIA (body ache), HEADACHE (headache) and NAUSEA (nausea) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced LYMPHADENOPATHY (swelling of the lymph node and under the armpit), VACCINATION SITE PAIN (pain at the injection site, tenderness at the injection site), MYALGIA (body ache), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, LYMPHADENOPATHY (swelling of the lymph node and under the armpit), VACCINATION SITE PAIN (pain at the injection site, tenderness at the injection site), MYALGIA (body ache), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Patient reported using warm showers as treatment.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up document is received doesn't have any new information
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on his face; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles on his face) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013l2ga and 001b21a) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (milk causes swelling of mouth and throat usually mild). Concomitant products included ACETYLSALICYLIC ACID (ASPRIN) for an unknown indication.   On 14-Jan-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021 at 2:40 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2021, the patient experienced HERPES ZOSTER (Shingles on his face). The patient was treated with PREDNISONE ongoing since an unknown date for Shingles, at a dose of 1 dosage form. On 17-Feb-2021, HERPES ZOSTER (Shingles on his face) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment information included prednisone and antiviral to treat the shingles.    Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: Patient demographics, medical history, suspect product details, concomitant medication, event details and outcome were updated.; Sender's Comments: Limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and MYALGIA (Body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and MYALGIA (Body aches). At the time of the report, HEADACHE (Headache) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Patient stated that she received the second dose of the Moderna COVID-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 contains non significant information. The primary reporter contact information has been updated.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Influenza like illness, Vomiting
Clinical narrative: Felt like she had the flu but ten times worse; Diarrhea; Vomiting; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like she had the flu but ten times worse), DIARRHOEA (Diarrhea) and VOMITING (Vomiting) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Celiac disease, Fibromyalgia and Hashimoto's disease. Concomitant products included DULOXETINE, CELECOXIB (CELEBREX) and GABAPENTIN for an unknown indication.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and VOMITING (Vomiting). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she had the flu but ten times worse). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like she had the flu but ten times worse), DIARRHOEA (Diarrhea) and VOMITING (Vomiting) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Treatment information was not provided.
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Myalgia, Rash macular
Clinical narrative: Red spot; muscle pain/muscle pain from her back to her buttocks; cannot move and does not want anyone touching it; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (cannot move and does not want anyone touching it), RASH MACULAR (Red spot) and MYALGIA (muscle pain/muscle pain from her back to her buttocks) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MOVEMENT DISORDER (cannot move and does not want anyone touching it) and MYALGIA (muscle pain/muscle pain from her back to her buttocks). On 10-Feb-2021, the patient experienced RASH MACULAR (Red spot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOVEMENT DISORDER (cannot move and does not want anyone touching it), RASH MACULAR (Red spot) and MYALGIA (muscle pain/muscle pain from her back to her buttocks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: follow-up reported on 22-Apr-2021 the patient said that they did not have any side effects after mentioning the reported events.She said they are doing fine and the events are not related to them and mentioned may be some one else but not them.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches) and PYREXIA (Low fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Aches) and PYREXIA (Low fever). At the time of the report, MYALGIA (Aches) and PYREXIA (Low fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Red marks on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red marks on injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red marks on injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red marks on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: On 05-May-2021, the patient reports that the events lasted for only couple days and everything is fine no.